The Journal of Clinical Hypertension (Apr 2021)
India Hypertension Control Initiative—Hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics
- Prabhdeep Kaur,
- Abhishek Kunwar,
- Meenakshi Sharma,
- Jhilam Mitra,
- Chinmoyee Das,
- Leimapokpam Swasticharan,
- Tapas Chakma,
- Sampada Dipak Bangar,
- Vettrichelvan Venkatasamy,
- Raviteja Dharamsoth,
- Saurabh Purohit,
- Sadhana Tayade,
- Gurinder B Singh,
- Sailaja Bitragunta,
- Kiran Durgad,
- Bidisha Das,
- Sunil Dar,
- Rupali Bharadwaj,
- Chakshu Joshi,
- Vishwajit Bharadwaj,
- Suhas Khedkar,
- Sravan Chenji,
- Sravan K Reddy,
- Chintala Sreedhar,
- Ganeshkumar Parasuraman,
- Savitha Kasiviswanathan,
- Vidhya Viswanathan,
- Pankaj Uike,
- Pooja Gaigaware,
- Suniti Yadav,
- RS Dhaliwal,
- Sivasubramanian Ramakrishnan,
- Fikru T Tullu,
- Balram Bhargava
Affiliations
- Prabhdeep Kaur
- ICMR‐National Institute of Epidemiology Chennai India
- Abhishek Kunwar
- WHO Country Office for India New Delhi India
- Meenakshi Sharma
- Indian Council of Medical Research (ICMR) New Delhi India
- Jhilam Mitra
- ICMR‐National Institute of Epidemiology Chennai India
- Chinmoyee Das
- Directorate General of Health Services I Ministry of Health and Family Welfare New Delhi India
- Leimapokpam Swasticharan
- Directorate General of Health Services I Ministry of Health and Family Welfare New Delhi India
- Tapas Chakma
- ICMR‐National Institute of Research in Tribal Health Jabalpur India
- Sampada Dipak Bangar
- ICMR‐National AIDS Research Institute Pune India
- Vettrichelvan Venkatasamy
- ICMR‐National Institute of Epidemiology Chennai India
- Raviteja Dharamsoth
- State NCD Cell Department of Health, Medical and Family Welfare Govt of Telangana Hyderabad India
- Saurabh Purohit
- State NCD Cell Directorate of Health Services Govt of Madhya Pradesh Bhopal India
- Sadhana Tayade
- State NCD Cell Directorate of Health Services Govt of Maharashtra Mumbai India
- Gurinder B Singh
- State NCD Cell Department of Health and Family Welfare Govt of Punjab Chandigarh India
- Sailaja Bitragunta
- ICMR‐National Institute of Epidemiology Chennai India
- Kiran Durgad
- WHO Country Office for India New Delhi India
- Bidisha Das
- WHO IHCI Project Punjab India
- Sunil Dar
- WHO IHCI Project Punjab India
- Rupali Bharadwaj
- WHO IHCI Project Madhya Pradesh India
- Chakshu Joshi
- WHO IHCI Project Madhya Pradesh India
- Vishwajit Bharadwaj
- WHO IHCI Project Maharashtra India
- Suhas Khedkar
- WHO IHCI Project Maharashtra India
- Sravan Chenji
- WHO IHCI Project Telangana India
- Sravan K Reddy
- WHO IHCI Project Telangana India
- Chintala Sreedhar
- WHO IHCI Project Telangana India
- Ganeshkumar Parasuraman
- ICMR‐National Institute of Epidemiology Chennai India
- Savitha Kasiviswanathan
- ICMR‐National Institute of Epidemiology Chennai India
- Vidhya Viswanathan
- ICMR‐National Institute of Epidemiology Chennai India
- Pankaj Uike
- ICMR‐National Institute of Research in Tribal Health Jabalpur India
- Pooja Gaigaware
- ICMR‐National AIDS Research Institute Pune India
- Suniti Yadav
- Indian Council of Medical Research (ICMR) New Delhi India
- RS Dhaliwal
- Indian Council of Medical Research (ICMR) New Delhi India
- Sivasubramanian Ramakrishnan
- All India Institute of Medical Sciences New Delhi India
- Fikru T Tullu
- WHO Country Office for India New Delhi India
- Balram Bhargava
- Indian Council of Medical Research (ICMR) New Delhi India
- DOI
- https://doi.org/10.1111/jch.14141
- Journal volume & issue
-
Vol. 23,
no. 4
pp. 720 – 729
Abstract
Abstract The India Hypertension Control Initiative (IHCI) is a multi‐partner initiative, implementing and scaling up a public health hypertension control program across India. A cohort of 21,895 adult hypertension patients in 24 IHCI sentinel site facilities in four Indian states (Punjab, Madhya Pradesh, Maharashtra, and Telangana), registered from January 2018 until June 2019 were assessed at baseline and then followed up for blood pressure (BP) control and antihypertensive medication use. Among all registrations, 11 274 (51%) of the patients returned for a follow‐up visit between July 2019 and September 2019. Among patients returning for follow‐up, 26.3% had BP controlled at registration, and 59.8% had BP controlled at follow‐up (p < .001). The absolute improvement in BP control was more than two times greater in primary care (48.1 percentage point increase) than secondary care facilities (22.9 percentage point increase). Most IHCI patients received prescriptions according to state‐specific treatment protocols. This study demonstrates that a scalable public health hypertension control program can yield substantial BP control improvements, especially in primary care settings. However, high loss to follow‐up limits population health impact; future efforts should focus on improving systems to increase the likelihood that patients will return to the clinic for routine hypertension care.
Keywords